Clinical Trial Update: Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating strategies for switching schizophrenia patients to aripiprazole from other antipsychotics; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: DSM-IV Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED